Drugs / HyperAcute - Breast cancer vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00090480 | Aug 2004 → Sep 2007 | breast cancer | NewLink Genetics Corporation | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HyperAcute - Breast cancer vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00090480 ↗ |
| Modality | Vaccine | “genetically engineered HyperAcute-Breast cancer vaccine” NCT00090480 ↗ |